English | Español
Patient Daily | Feb 11, 2026

Obesity drug market sees advances in oral therapies amid pricing deals and access concerns
Patient Daily | Feb 11, 2026

Eli Lilly acquisition highlights surge in interest for in vivo gene therapies
Patient Daily | Feb 11, 2026

Pelage Pharmaceuticals advances stem cell-based therapy for pattern hair loss
Patient Daily | Feb 10, 2026

Amgen ends partnership with Kyowa Kirin on autoimmune drug rocatinlimab
Patient Daily | Feb 10, 2026

FDA flagged key issues early before rejecting Corcept’s hypercortisolism drug
Patient Daily | Feb 10, 2026

Sanofi reports mixed phase III results for rare disease drug venglustat
Patient Daily | Feb 10, 2026

Eli Lilly invests $3.5 billion in Pennsylvania obesity drug manufacturing plant
Patient Daily | Feb 10, 2026

GSK ends partnership on WVE-006 for AATD; future collaborations with Wave continue

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'
Patient Daily | Apr 8, 2026

Breathe Free Teams Pack Meals at Community Volunteer Event, Expanding Care Beyond Clinics